Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

COVID-19

Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2

Nature Immunology volume 24, pages 1594–1596 (2023)Cite this article

Subjects

After vaccination, spike-specific CD8+ T cells play an important part in the immediate immune response to breakthrough SARS-CoV-2 infection, whereas the B cell and neutralizing antibody responses come into effect 2 weeks after infection.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Dynamics of the immune adaptive and humoral immune responses to vaccination and breakthrough infection.

References

  1. Zhang, B. et al. Nat Immunol. https://doi.org/10.1038/s41590-023-01608-9 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Painter, M. M. et al. Nat Immunol. https://doi.org/10.1038/s41590-023-01613-y (2023).

    Article  PubMed  Google Scholar 

  3. Peng, Y. et al. Nat. Immunol. 23, 50–61 (2022).

    Article  CAS  PubMed  Google Scholar 

  4. Peng, Y. et al. Nat. Immunol. 21, 1336–1345 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Minervina, A. A. et al. Nat. Immunol. 23, 781–790 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Cell 185, 916–938.e958 (2022).

  7. Hao, Y. H. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01767-y (2023).

    Article  PubMed  Google Scholar 

  8. Simnica, D. et al. Clin. Transl. Immunol. 10, e1340 (2021).

    Article  CAS  Google Scholar 

  9. Chaisawangwong, W. et al. JCI Insight 7, e158308 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Poon, M. M. L. et al. Sci. Immunol. 6, eabl9105 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Diniz, M. O. et al. Nat. Immunol. 23, 1324–1329 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhao, Y. et al. Am. J. Resp. Crit. Care 186, 1292–1297 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work is supported by the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (grant number 2018-I2M-2-002) and the UK Medical Research Council.

Author information

Authors and Affiliations

  1. Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK

    Elie Antoun, Yanchun Peng & Tao Dong

  2. MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK

    Tao Dong

Authors
  1. Elie Antoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanchun Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tao Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tao Dong.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antoun, E., Peng, Y. & Dong, T. Vaccine-induced CD8+ T cells are key to protection from SARS-CoV-2. Nat Immunol 24, 1594–1596 (2023). https://doi.org/10.1038/s41590-023-01621-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-023-01621-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing